FDA NDC Directory · JSON-LD · Markdown

LANOXIN

NDC 59212-240 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namedigoxin
Labeler / ManufacturerAdvanz Pharma (US) Corp.
Marketing categoryNew Drug Application (innovator) · App NDA020405
Dosage form / routeTABLET · ORAL
Active ingredientsDIGOXIN (.0625 mg/1)
Marketing started20120930
Package count1

External sources

Source: openFDA. Public-domain (CC0).